Virtue Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Buy
2,019
+117
+6% +$120K 1.7% 16
2026
Q1
$1.75M Sell
1,902
-24
-1% -$24.3K 1.39% 21
2025
Q4
$2.07M Buy
1,926
+26
+1% +$24.9K 1.65% 18
2025
Q3
$1.45M Buy
+1,900
New +$1.41M 1.2% 25

Other funds holding LLY

Virtue Asset Management's LLY Position: Q2 2026 in Review

Virtue Asset Management increased its Eli Lilly (LLY) stake by 6.2% in Q2 2026, buying an estimated $120K and bringing the position to 2,019 shares worth $2.42M. The position accounts for 1.7% of the portfolio, ranked #16.

Virtue Asset Management first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Virtue Asset Management held 2,019 shares of Eli Lilly worth $2.42M as of Q2 2026.
  • Virtue Asset Management bought 117 Eli Lilly shares in Q2 2026, an estimated $120K.
  • Eli Lilly made up 1.7% of Virtue Asset Management's portfolio in Q2 2026, its #16 holding.
  • Virtue Asset Management first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Virtue Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.